| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2004;128:138-146
© 2004 The American Association for Thoracic Surgery
General thoracic surgery |
a Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Mass, USA
b Division of Thoracic Surgery, Mt Sinai Hospital and Medical Center, New York, NY, USA
Read at the Eighty-third Annual Meeting of The American Association for Thoracic Surgery, Boston, Mass, May 4-7, 2003.
Received for publication June 17, 2003; revisions received February 2, 2004; accepted for publication February 10, 2004.
* Address for reprints: David J. Sugarbaker, MD, Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis St, Boston MA 02115, USA
dsugarbaker{at}partners.org
OBJECTIVE: Extrapleural pneumonectomy for therapy of mesothelioma has been associated with significant perioperative mortality and morbidity. Postoperative complications of this procedure require a unique management approach. We developed treatment algorithms for most of the common complications of extrapleural pneumonectomy resulting in reduced mortality and hospital stay. Complications after extrapleural pneumonectomy were further analyzed to elucidate means of prevention, early detection, and treatment.
METHODS: A total of 496 patients undergoing extrapleural pneumonectomy were reviewed for mortality rates, with a subset of 328 consecutive patients between 1980 and 2000 who were examined for detailed morbidity data by using a prospective clinical database.
RESULTS: Median age was 58 years (range, 28-77 years), with a 10-day (range, 4-101 days) median length of stay. One hundred ninety-eight (60.4%) of 328 patients experienced minor and major complications, and 11 of 328 patients died, for an overall mortality rate of 3.4%. Complications included the following: atrial fibrillation (145 [44.2%]), prolonged intubation (26 [7.9%]), vocal cord paralysis (22 [6.7%]), deep vein thrombosis (21 [6.4%]), technical complications (patch dehiscence, hemorrhage, or both; 20 [6.1%]), tamponade (12 [3.6%]), acute respiratory distress syndrome (12 [3.6%]), cardiac arrest (10 [3%]), constrictive physiology (9 [2.7%]), aspiration (9 [2.7%]), renal failure (9 [2.7%]), empyema (8 [2.4%]), tracheostomy (6 [1.8%]), myocardial infarction (5 [1.5%]), pulmonary embolus (5 [1.5%]), and bronchopleural fistula (2 [0.6%]). Clinical data demonstrated the following: (1) prophylaxis for atrial fibrillation is recommended; (2) early ambulation, aspiration precautions, endoscopic assessment of the vocal cords, and avoidance of fluid overload are crucial; (3) perioperative diagnosis and aggressive management of deep vein thrombosis are important; (4) immediate reoperation and open cardiac massage are essential for relief of cardiac herniation and tamponade from cardiac patch dysfunction; (5) diaphragmatic patch dehiscence, hemorrhage, or both require immediate reoperation; (6) early signs of infection might indicate bronchopleural fistula or empyema and should be treated with thoracoscopic or open drainage and staged removal of patch material; and (7) excessive perioperative mediastinal shift is treated with a catheter placed intraoperatively.
CONCLUSION: Complications after extrapleural pneumonectomy require a unique approach to management, and mortality can be minimized by early detection and aggressive treatment.
This article has been cited by other articles:
|
|
 |
|
  A.-M. Hamad, G. Marulli, F. Sartori, and F. Rea Pericardial flap for bronchial stump coverage after extrapleural pneumonectomy; is it feasible? Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1255 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Neragi-Miandoab, S. Weiner, and D. J. Sugarbaker Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesothelioma Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1039 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Sorensen, J. Ravn, A. Loft, J. Brenoe, A. K. Berthelsen, and on behalf of the Nordic Mesothelioma Group Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 1090 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakas, D. S. Trousse, A. E. Martin-Ucar, and D. A. Waller Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 886 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Tournoy, S. A. Burgers, J. T. Annema, F. Vermassen, M. Praet, M. Smits, H. M. Klomp, J. P. van Meerbeeck, and P. Baas Transesophageal Endoscopic Ultrasound with Fine Needle Aspiration in the Preoperative Staging of Malignant Pleural Mesothelioma Clin. Cancer Res., October 1, 2008; 14(19): 6259 - 6263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kakadellis and E. A. Karfis The posterior membranous flap technique for bronchial closure after pneumonectomy Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 638 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. West and D. Prakash Aprotinin and extrapleural pneumonectomy. Ann. Thorac. Surg., July 1, 2008; 86(1): 354 - 355. [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. van Sandick, I. Kappers, P. Baas, R. L. Haas, and H. M. Klomp Surgical Treatment in the Management of Malignant Pleural Mesothelioma: A Single Institution's Experience Ann. Surg. Oncol., June 1, 2008; 15(6): 1757 - 1764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Geerts, D. Bergqvist, G. F. Pineo, J. A. Heit, C. M. Samama, M. R. Lassen, and C. W. Colwell Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 381S - 453S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Perrot, K. McRae, M. Anraku, K. Karkouti, T. K. Waddell, A. F. Pierre, G. Darling, S. Keshavjee, and M. R. Johnston Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma Ann. Thorac. Surg., April 1, 2008; 85(4): 1206 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shiomi, Y. Hagiwara, K. Sonoue, T. Segawa, K. Miyashita, M. Maeda, H. Izumi, K. Masuda, M. Hirabayashi, T. Moroboshi, et al. Sensitive and Specific New Enzyme-Linked Immunosorbent Assay for N-ERC/Mesothelin Increases its Potential as a Useful Serum Tumor Marker for Mesothelioma Clin. Cancer Res., March 1, 2008; 14(5): 1431 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Schipper, F. C. Nichols, K. M. Thomse, C. Deschamps, S. D. Cassivi, M. S. Allen, and P. C. Pairolero Malignant Pleural Mesothelioma: Surgical Management in 285 Patients Ann. Thorac. Surg., January 1, 2008; 85(1): 257 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Kindler, R. Bueno, and J. R. Testa New Biomarkers, Surgical Controversies, and Rationally Targeted Therapies for Malignant Mesothelioma ASCO Educational Book, January 1, 2008; 2008(1): 354 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huang, N. P. Rizk, W. D. Travis, V. E. Seshan, M. S. Bains, J. Dycoco, R. J. Downey, R. M. Flores, B. J. Park, and V. W. Rusch Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1477 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 British Thoracic Society Standards of Care Committ BTS statement on malignant mesothelioma in the UK, 2007 Thorax, November 1, 2007; 62(Suppl_2): ii1 - ii19. [Full Text] [PDF]
|
|
|
|
 |
|
 W Weder, R. Stahel, J Bernhard, S Bodis, P Vogt, P Ballabeni, D Lardinois, D Betticher, R Schmid, R Stupp, et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma Ann. Onc., July 1, 2007; 18(7): 1196 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Ceresoli, C. Gridelli, and A. Santoro Multidisciplinary Treatment of Malignant Pleural Mesothelioma Oncologist, July 1, 2007; 12(7): 850 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Martin-Ucar, A. Nakas, J. G. Edwards, and D. A. Waller Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 765 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Cameron Extrapleural Pneumonectomy Is the Preferred Surgical Management in the Multimodality Therapy of Pleural Mesothelioma: Con Argument Ann. Surg. Oncol., April 1, 2007; 14(4): 1249 - 1253. [Full Text] [PDF]
|
|
|
|
|
|
W. B. Keeling, V. Lewis, E. Blazick, T. S. Maxey, J. R. Garrett, and K. E. Sommers Routine Evaluation for Aspiration After Thoracotomy for Pulmonary Resection Ann. Thorac. Surg., January 1, 2007; 83(1): 193 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Opitz, P. Kestenholz, D. Lardinois, M. Muller, V. Rousson, D. Schneiter, R. Stahel, and W. Weder Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 579 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Ceresoli, P. A. Zucali, A. G. Favaretto, F. Grossi, P. Bidoli, G. Del Conte, A. Ceribelli, A. Bearz, E. Morenghi, R. Cavina, et al. Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma J. Clin. Oncol., March 20, 2006; 24(9): 1443 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Thromboembolism after pneumonectomy for malignancy: An independent marker of poor outcome. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 711 - 718.
|
|
|
|
|
|
S. Neragi-Miandoab Multimodality approach in management of malignant pleural mesothelioma Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 14 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Robinson and R. A. Lake Advances in malignant mesothelioma. N. Engl. J. Med., October 13, 2005; 353(15): 1591 - 1603. [Full Text] [PDF]
|
|
|
|
|
|
J.M. Alvarez, T. Ha, W. Musk, P. Robins, R. Price, and M.J. Byrne Importance of mediastinoscopy, bilateral thoracoscopy, and laparoscopy in correct staging of malignant mesothelioma before extrapleural pneumonectomy J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 905 - 906. [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Argote-Greene, M. Y. Chang, and D. J. Sugarbaker Extrapleural pneumonectomy for malignant pleural mesothelioma MMCTS, June 28, 2005; 2005(0628): 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lang-Lazdunski, C. Tan, and T. Treasure Extrapleural pneumonectomy for malignant mesothelioma: Should pericardium be resected routinely? J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1202 - 1202. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Stewart, A. E. Martin-Ucar, J. G. Edwards, K. West, and D. A. Waller Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 373 - 378. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
